Meanwhile, considering that excessive activation of PARP1 consumes a large amount of intracellular NAD+, leading to energy metabolism disorders and further aggravating cell death, we also plan to use NAD+ precursor substances (e.g., β-nicotinamide mononucleotide, NMN) for intervention in subsequent studies. Here, PARP1 is linked to metabolic disease.